Search
for
Sort by
Research 511–540 of 715
- Global sex disparities in lifetime risk of alopecia areata: a systematic analysis from the global burden of disease study, 1990 to 2021
- Overlapping features of atopic dermatitis and alopecia areata: from pathogenesis to treatment
- Detection of Serum Levels of Interleukins-17, 21, 6 and Tumor Necrosis Factor-α in Patients with Patchy Alopecia Areata and Their Association with Disease Severity
- Development and Evaluation of Nanoemulgel Loaded with Minoxidil
- Research progress in the treatment of non-scarring alopecia: mechanism and treatment
- Carotid Intima Media Thickness Measurement in Alopecia Areata Patients
- Alopecia Areata Possibly Secondary to COVID-19 Vaccine
- Trichoscopy in the Diagnosis of Alopecia Areata
- Comparative Efficacy and Safety of Baricitinib Against Traditional Therapies in Severe Alopecia Areata: A Retrospective Cohort Study
- Update on Platelet-Rich Plasma and Platelet-Rich Fibrin for Dermatologic Surgery: Addressing Knowns and Unknowns
- The Roles of Exosomes in Regulating Hair Follicle Growth
- Alopecia Universalis with Frequently Relapsing Nephrotic Syndrome of Infantile Onset: A Rare Presentation
- Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- An Updated in the Management of Alopecia Areata
- Review on Alopecia Areata in the Middle East and Africa: Landscape and Unmet Needs
- Alopecia areata
- Alopecia Areata in Latin America: Where are We and Where are We Going?
- Sesame and Pumpkin Seed Oil are New Effective Topical Therapies for Alopecia Areata
- Global, regional and national burden of alopecia areata from 1990 to 2021: a systematic analysis of the global burden of disease study 2021, with predictions to 2040
- Revolutionary Approaches to Hair Regrowth: Follicle Neogenesis, Wnt/ß-Catenin Signaling, and Emerging Therapies
- Comparison of Safety and Efficacy of Topical Mometasone 0.1% Ointment, Calcipotriol 0.005% Ointment, and Tacrolimus 0.1% Ointment in Patients with Localized Alopecia Areata: A Triple-Arm Randomized Clinical Study
- Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries
- Mendelian randomization study highlights hypothyroidism as a causal determinant of alopecia areata
- A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Platelet-rich plasma in alopecia areata and primary cicatricial alopecias: A systematic review
- ANALYSIS OF EFFICACY OF USING PLATELET-RICH PLASMA AND BETAMETHAZONE IN THE TREEATMENT OF ALOPECIA AREATA
- Application of Baricitinib in Dermatology
- Successful treatment of corticosteroid-resistant ophiasis-type alopecia areata (AA) with platelet-rich plasma (PRP)
- Case of intractable ophiasis type of alopecia areata presumably improved by fexofenadine